Sandoz Sunitinib 25 mg (Sunitinib CAPSULE) 25 MG

Sandoz Sunitinib 25 mg capsules are a pharmaceutical product used for targeted therapy. This oral medication is designed to support specific treatment protocols as prescribed by healthcare professionals.

Strength

25 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sunitinib is primarily used in the management of certain types of cancer. It works by inhibiting specific proteins that can contribute to cancer cell growth. Patients often wonder, 'What is Sunitinib used for?' This medication is typically prescribed for advanced or metastatic cancers, though specific uses may vary based on individual health conditions.

Side Effects

Common effects of Sunitinib may include fatigue, nausea, and changes in skin or hair. Some users also report mild gastrointestinal discomfort. These effects can vary widely among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

Sunitinib should be handled with care and stored as directed. It is important to follow the guidance of a healthcare professional regarding administration and storage. Pregnant women or those planning to become pregnant should consult their doctor before use.

Avoid Interactions

Sunitinib may interact with certain medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how Sunitinib works in the body.

Frequently Asked Questions

Sunitinib is used in the treatment of certain types of cancer, targeting specific proteins involved in cancer cell growth.

Sunitinib capsules are taken orally, typically with water. Always follow the instructions provided by your healthcare professional.

Common side effects may include fatigue, nausea, and skin changes. Individual experiences can vary.

Sunitinib may interact with other medications. Consult your healthcare provider for personalized advice.

Pregnant women should consult their doctor before taking Sunitinib, as it may have specific risks during pregnancy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.